Trial Profile
A multicenter, open, phase IV, 24-hour ambulatory blood pressure monitoring study of the efficacy and safety of Tarka [verapamil/trandolapril] in patients with arterial hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Mar 2009
Price :
$35
*
At a glance
- Drugs Verapamil/trandolapril (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 09 Jul 2008 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 09 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 09 Jul 2008 Actual patient number (120) added as reported by ClinicalTrials.gov.